Bcm Advisors, LLC Pfizer Inc Transaction History

Bcm Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $173,308 - $203,085	6,861 New	6,861 $191,000
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $23,318 - $30,357	592 Added 11.67%	5,666 $231,000
Q3 2022 Nov 02, 2022	SELL	$43.76 - $53.42 $16,016 - $19,551	-366 Reduced 6.73%	5,074 $241,000
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $17,029 - $20,192	366 Added 7.21%	5,440 $282,000
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $182,207 - $206,410	5,074 New	5,074 $204,000
Q1 2021 Apr 28, 2021	SELL	$33.49 - $37.77 $203,418 - $229,414	-6,074 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $192,849 - $226,256	6,074 New	6,074 $215,000
Q3 2019 Oct 23, 2019	SELL	$32.49 - $42.13 $164,854 - $213,767	-5,074 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$34.47 - $41.81 $174,900 - $212,143	5,074 New	5,074 $224,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bcm Advisors, LLC with notifications on news.